Paper41978147
Protective Effects of Vitamin D Against Doxorubicin Chemotherapy-Induced Hepatotoxicity in Wistar Albino Rats: Evidence from 99mTc-Pyrophosphate Scintigraphy and Oxidative-Inflammatory Pathways.
Kalın M and 8 others. Nutrients, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Protective Effects of Vitamin D Against Doxorubicin Chemotherapy-Induced Hepatotoxicity in Wistar Albino Rats: Evidence from 99mTc-Pyrophosphate Scintigraphy and Oxidative-Inflammatory Pathways. Papers, record 41978147. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41978147
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Protective Effects of Vitamin D Against Doxorubicin Chemotherapy-Induced Hepatotoxicity in Wistar Albino Rats: Evidence from 99mTc-Pyrophosphate Scintigraphy and Oxidative-Inflammatory Pathways.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Doxorubicin | Major topic |
| Oxidative Stress | Major topic |
| Chemical and Drug Induced Liver Injury | Major topic |
| Vitamin D | Major topic |
| Antibiotics, Antineoplastic | Major topic |
| Animals | |
| Rats, Wistar | |
| Male | |
| Liver | |
| Rats | |
| Radionuclide Imaging | |
| Inflammation | |
| Antioxidants | |
| Biomarkers | |
| Cholecalciferol |
Source PubMed
References71
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28516789 | Protective effect of pravastatin on doxorubicin-induced hepatotoxicity. | Bratisl Lek Listy | 2017 | https://conductscience.org/library/papers/28516789 | PubMed |
| 2 | 38053572 | Nephroprotective effects of diminazene on doxorubicin-induced acute kidney injury in rats. | Toxicol Rep | 2023 | https://conductscience.org/library/papers/38053572 | PubMed |
| 3 | 38104651 | Vitamin D Receptor Activation Reduces Hepatic Inflammation via Enhancing Macrophage Autophagy in Cholestatic Mice. | Am J Pathol | 2024 | https://conductscience.org/library/papers/38104651 | PubMed |
| 4 | 32234491 | New molecular and biochemical insights of doxorubicin-induced hepatotoxicity. | Life Sci | 2020 | https://conductscience.org/library/papers/32234491 | PubMed |
| 5 | 38648220 | Doxorubicin causes cachexia, sarcopenia, and frailty characteristics in mice. | PLoS One | 2024 | https://conductscience.org/library/papers/38648220 | PubMed |
| 6 | 40602439 | NLRP3 inflammasome regulates doxorubicin-induced cardiotoxicity by modulating the abundance of gut microbiota. | Toxicol Appl Pharmacol | 2025 | https://conductscience.org/library/papers/40602439 | PubMed |
| 7 | 18694980 | Vitamin D and human health: lessons from vitamin D receptor null mice. | Endocr Rev | 2008 | https://conductscience.org/library/papers/18694980 | PubMed |
| 8 | 21048526 | Doxorubicin pathways: pharmacodynamics and adverse effects. | Pharmacogenet Genomics | 2011 | https://conductscience.org/library/papers/21048526 | PubMed |
| 9 | 30830277 | Mechanisms of vitamin D on skeletal muscle function: oxidative stress, energy metabolism and anabolic state. | Eur J Appl Physiol | 2019 | https://conductscience.org/library/papers/30830277 | PubMed |
| 10 | 31600860 | Doxorubicin-induced skeletal muscle atrophy: Elucidating the underlying molecular pathways. | Acta Physiol (Oxf) | 2020 | https://conductscience.org/library/papers/31600860 | PubMed |
| 11 | 33652780 | Nrf2 Signaling Pathway in Chemoprotection and Doxorubicin Resistance: Potential Application in Drug Discovery. | Antioxidants (Basel) | 2021 | https://conductscience.org/library/papers/33652780 | PubMed |
| 12 | 32384521 | The effect of vitamin D supplementation on the progression of fibrosis in patients with chronic liver disease: A protocol for a systematic review and meta-analysis. | Medicine (Baltimore) | 2020 | https://conductscience.org/library/papers/32384521 | PubMed |
| 13 | 1834386 | Liver uptake of Tc-99m PYP. | Clin Nucl Med | 1991 | https://conductscience.org/library/papers/1834386 | PubMed |
| 14 | 40319302 | Protective effects of Alamandine against doxorubicin-induced liver injury in rats. | BMC Pharmacol Toxicol | 2025 | https://conductscience.org/library/papers/40319302 | PubMed |
| 15 | 40894204 | Doxorubicin-induced nephrotoxicity: the protective role of a standardized ethanolic extract of Andrographis paniculata leaves. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/40894204 | PubMed |
| 16 | 38796137 | Vitamin D Metabolites Before and After Kidney Transplantation in Patients Who Are Anephric. | Am J Kidney Dis | 2024 | https://conductscience.org/library/papers/38796137 | PubMed |
| 17 | 22596255 | The nonskeletal effects of vitamin D: an Endocrine Society scientific statement. | Endocr Rev | 2012 | https://conductscience.org/library/papers/22596255 | PubMed |
| 18 | 34092215 | CD36 deficiency ameliorates drug-induced acute liver injury in mice. | Mol Med | 2021 | https://conductscience.org/library/papers/34092215 | PubMed |
| 19 | 18830610 | Chemotherapy is linked to severe vitamin D deficiency in patients with colorectal cancer. | Int J Colorectal Dis | 2009 | https://conductscience.org/library/papers/18830610 | PubMed |
| 20 | 28718673 | Ameliorative Effect of Gallic Acid in Doxorubicin-Induced Hepatotoxicity in Wistar Rats Through Antioxidant Defense System. | J Diet Suppl | 2018 | https://conductscience.org/library/papers/28718673 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41978147
GET https://conductscience.org/api/papers/v1/41978147/references?page=2